Concord Biotech informs about successful completion of NAFDAC inspection

08 Oct 2025 Evaluate
Concord Biotech has announced the successful completion of NAFDAC inspection (National Agency for Food and Drug Administration) at our Oral Solid Dosage (OSD) Unit-2, facility located at Valthera, Gujarat. The inspection was conducted from October 06’ 2025 to October 07’ 2025. This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of our operations. It reflects its dedication to excellence and its continued focus on meeting the rigorous requirements of global regulatory authorities. 

The above information is a part of company’s filings submitted to BSE. 

Concord Biotech Share Price

1347.60 -2.95 (-0.22%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×